Does DULAGLUTIDE Cause Neoplasm malignant? 176 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Neoplasm malignant have been filed in association with DULAGLUTIDE (Trulicity). This represents 0.2% of all adverse event reports for DULAGLUTIDE.
176
Reports of Neoplasm malignant with DULAGLUTIDE
0.2%
of all DULAGLUTIDE reports
13
Deaths
23
Hospitalizations
How Dangerous Is Neoplasm malignant From DULAGLUTIDE?
Of the 176 reports, 13 (7.4%) resulted in death, 23 (13.1%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULAGLUTIDE. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does DULAGLUTIDE Cause?
Injection site pain (9,474)
Nausea (9,137)
Blood glucose increased (9,119)
Incorrect dose administered (5,207)
Diarrhoea (5,036)
Vomiting (4,880)
Inappropriate schedule of product administration (3,606)
Extra dose administered (3,047)
Injection site haemorrhage (3,028)
Weight decreased (3,000)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DULAGLUTIDE Alternatives Have Lower Neoplasm malignant Risk?
DULAGLUTIDE vs DULERA
DULAGLUTIDE vs DULOXETINE
DULAGLUTIDE vs DUPILUMAB
DULAGLUTIDE vs DURAGESIC
DULAGLUTIDE vs DUROGESIC